1. Richard A Proctor is Professor Emeritus in the Departments of Medicine and Medical Microbiology, University of Wisconsin Medical School in Madison (USA), retired from Merck (PA, USA) as the Global Director for Infectious Diseases for Antibiotics and Antifungals, and continues an active consulting career for industry/universities/research funding agencies; collaborating with multiple university professors and companies doing research on staphylococcal infections, new antimicrobials and rapid diagnostics;...
2. Drew Smith was a founding scientist at NeXagen (later NeXstar) in CO, USA, where he published the first demonstration of therapeutic efficacy in an animal model of disease by an aptamer drug candidate. He joined MicroPhage (CO, USA) in 2006 as Director of R&D, where his team developed a bacteriophage-based test for S. aureus bloodstream infections, which was recognized by R&D Magazine as one of the top 100 inventions of 2010. As Chief Science Officer and interim CEO, he was responsible for US FDA...